Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease

Archives of Neurology

Volumn 53, Issue 4, 1996, Pages 345-350

  Dal Forno, Gloria ^a   Rasmusson, D Xeno ^a   Brandt, Jason ^a   Carson, Kathryn A ^a   Brookmeyer, Ronald ^a,b   Troncoso, Juan ^a   Kawas, Claudia H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HUMAN; HYPERLIPOPROTEINEMIA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RISK ASSESSMENT;

EID: 0029987155     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550040085017     Document Type: Article

References (56)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
2. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci U S A. 1993;90: 9649-9653.
3. Saunders AM, Strittmatter WJ, Schmechel MD, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
4. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988,40:622-628.
5. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
6. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E ∈4 distribution in late-onset Alzheimer's disease and in other amyloid forming diseases. Lancet. 1993,342 710-711.
7. Menzel HJ, Kladetzky RG, Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis. 1983,3 310-315.
8. Mayeux R, Stern Y, Ottman R, et al. Apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol. 1993;34:752-754.
9. Poirier J, Davignon J, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993;342:697-699.
10. Payami H, Kaye J, Heston LL, Bird TD, Schellenberg TD. Apolipoprotein E genotype and Alzheimer's disease Lancet 1993;342:738.
11. Brogaonkar DS, Schmidt LC, Martin SE, et al. Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19. Lancet. 1993; 342:625.
12. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variations and receptor interactions Neuron. 1993; 11.575-580.
13. Brosseau T, Legrain S, Berr C, Gourlet V, Vidal O, Amouyel P. Confirmation of the ∈4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology. 1994;44 342-344.
14. Katzman R, Kawas CH. Note added in proof to chapter 8. In: Terry RD, Katzman R, Bick KL. Alzheimer's Disease. New York, NY; Raven Press; 1994: 455-457.
15. Strittmatter WJ, Weisgraber CH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filaments formation in the Alzheimer's disease brain are related to apolipoprotein E genotype. Exp Neurol. 1994;125:163-171.
16. Frisoni GB, Govoni S, Geroldi C, et al. Gene dose of the ∈4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol. 1995;37:596-604.
17. DeKosky ST, Ferrell R, Kamboh MI, Becker JT. Natural history of definite Alzheimer's disease as a function of APOE genotypes. Neurology. 1995;45.A373-A374. Abstract 767S
18. Gomez-Isla T, Rebeck GW, Growdon JH, Mui S, Brown RH, Hyman BT. Molecular epidemiology of Alzheimer's disease: effect of apolipoprotein E genotype. Neurology. 1995;45(suppl 4) A471. Abstract.
19. Koivisto K, Helkala EL, Hanninen T, et al The effect of apolipoprotein ∈4 allele on clinical progression of Alzheimer's disease. Neurology. 1995;45:A373. Abstract 766S.
20. Edland SD, Kukull WA, Schellenberg GD. Apolipoprotein E and rate of cognitive decline in Alzheimer's disease. Neurology. 1995;45:A213-A214. Abstract 192S.
21. Nacmias B, Campani D, Falcini M, et al. ApoE correlates with the presence and the severity of Alzheimer's disease in mental-impaired Italian patients. Neurology. 1995;45:A454 Abstract 1039P.
22. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease Neurology. 1995;45:1323-1328.
23. van Duijn CM, de Knijff P, Wehnert A, et al The apolipoprotein E ∈2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol. 1995,37.605-610
24. Rasmusson DX, Carson KA, Brookmeyer R, Kawas CH, Brandt J Predicting rate of cognitive decline in probable Alzheimer's disease. Brain Cogn. In press.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease, report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;11 939-944.
26. Mirra SS, Heyman, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), II standardization of the neuropathological assessment of Alzheimer's Disease Neurology. 1991;41:479-486.
27. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198
28. Moss MB, Albert MS, Butters N, Payne M. Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff syndrome. Arch Neurol. 1986;43:239-246.
29. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Boston, Mass: Kaplan & Goodglass; 1978.
30. Rosen WG Verbal fluency in aging and dementia J Clin Neuropsychol. 1980; 2.135-146.
31. Wilkinson IM, Graham-White J. Psychogeriatric dependency rating scales (PGDRS): a method of assessment for use by nurses. Br J Psychiatry. 1981; 137:558-565.
32. Wechsler D. WAIS Manual: Wechsler Adult Intelligence Scale. New York, NY: Psychological Corp; 1995.
33. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990,31.545-548.
34. Laird MM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963-974.
35. SAS Institute Inc. SAS/STAT Software. Changes and Enhancements, Release 6.07. Cary, NC. SAS Institute Inc; 1992:287-366. SAS Technical Report P-229
36. Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB. Cognitive decline in Alzheimer's disease a longitudinal investigation of risk factors for accelerated decline. J Gerontol. 1995;50 M49-M55.
37. Rasmusson DX, Barr A, Brandt J. Predictors of illness progression in Alzheimer's disease. Presented at the the 22nd Annual Meeting of the International Neuropsychological Society; February 3, 1994; Cincinnati, Ohio.
38. St George-Hyslop P, Haines JL, Farrer LA, et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature. 1990;347:194-197
39. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer's type: evidence of subgroups. Neurology. 1985,35:453-461.
40. Mortimer JA, French LR, Hutton JT, Schuman LM. Head injury as a risk factor for Alzheimer's disease. Neurology. 1985;35:264-267.
41. Mortimer JA, van Duijn CM, Chandra V, et al. Head trauma as a risk factor for Alzheimer's disease: a collaborative reanalysis of case-control studies. Int J Epidemiol. 1991;20(suppl):S28-S35.
42. van Duijn CM, Stijnen T, Hofman A. Risk factors for Alzheimer's disease: overview of the EURODEM collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(suppl):S4-S12.
43. Rasmusson DX, Brandt J, Martin DB, Folstein MF. Head injury in Alzheimer's disease Brain Inj. 1995,9:213-219.
44. van Duijn CM, Clayton D, Chandra V, et al. Familial aggregation of Alzheimer's disease and related disorders: a collaborative reanalysis of case-control studies. Int J Epidemiol. 1991;20(suppl 2):S13-S20.
45. Rocca WA, van Dujin CM, Clayton D, et al. Maternal age and Alzheimer's disease: a collaborative reanalysis of case-control studies. Int J Epidemiol. 1991; 20(suppl 2):S21-S27.
46. Hofman A, van Dujin CM, Schulte W, et al. Is parental age related to risk of Alzheimer's disease? Br J Psychiatry. 1990;157:273-275.
47. Katzman R. Alzheimer's disease. N Engl J Med. 1986;314.964-973
48. Graves AB, White E, Koepsell TD, Reifler BV, Belle GV, Larson EB. The association between aluminum-containing products and Alzheimer's disease. J Clin Epidemiol. 1990;4335-44.
49. Zhang M, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer's disease (AD) in Shanghai, China impact on age, gender and education. Ann Neurol. 1990;27:428-437.
50. Snowdon DA, Ostwald SK, Kane RL. Education, survival and independence in elderly catholic sisters, 1936-1988 Am J Epidemiol. 1989,130:999-1012.
51. Katzman R. Views and reviews: education and the prevalence of dementia and Alzheimer's disease Neurology. 1993;43:13-20.
52. Stern Y, Gurland B, Tatemichi, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994; 271:1004-1010
53. Amaducci LA, Fratiglioni L, Rocca WA, et al. Risk factors for clinically diagnosed Alzheimer's disease: a case control study of an Italian population Neurology. 1986;36:922-931.
54. Rebok G, Brandt J, Folstein M. Longitudinal cognitive decline in patients with Alzheimer's disease. J Geriatr Psychiatry Neurol. 1991;3:91-97
55. Duara R, Lopez-Alberola R, Barker WW, Grau L, Sevush S, St George-Hyslop P Age at onset of Alzheimer's disease (AD): interaction of gender, family history and apolipoprotein E genotype. Neurology. 1995;45:A470. Abstract 1101P.
56. Brandt J, Mellits ED, Rovner B, Gordon B, Selnes OA, Folstein MF Relation of age at onset and duration of illness to cognitive functioning in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol. 1989;2:93-101.